Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers

Daehwan Kim(Chung-Ang University), Mark R. Lackner(Zen-Noh (Japan))
npj Precision Oncology
January 4, 2025
Cited by 15


Related Papers